(Q36985258)

17 August 2017

1 reference

title

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis (English)

1 reference

17 August 2017

1 reference

0 references

Hale Ersoy

1

1 reference

PMCID

2709982

17 August 2017

Frank J Rybicki

series ordinal

2

1 reference

PMCID

2709982

17 August 2017

language of work or name

1 reference

1 November 2007

1 reference

Journal of Magnetic Resonance Imaging

17 August 2017

1 reference

17 August 2017

26

1 reference

17 August 2017

1190-1197

1 reference

17 August 2017

5

1 reference

MR contrast agents: physical and pharmacologic basics

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium deposition in nephrogenic fibrosing dermopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and interindividual comparison studies with gadopentetate dimeglumine.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Vasovist-enhanced MR angiography

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Nephrogenic systemic fibrosis: an update

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

When are two waters worse than one? Doubling the hydration number of a Gd-DTPA derivative decreases relaxivity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

The use of iodinated and gadolinium contrast media during pregnancy and lactation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Contrast agents for magnetic resonance imaging: safety update

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Safety of gadolinium contrast angiography in patients with chronic renal insufficiency

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium-containing contrast media for radiographic examinations: a position paper

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Basic experimental studies and clinical aspects of gadolinium salts and chelates

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Adverse reactions to gadolinium contrast media: a review of 36 cases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Biodistribution and toxicity of MR imaging contrast media

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Preservation of sickle cell blood-flow patterns during MR imaging: an in vivo study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Safety of gadolinium-DTPA: Extended clinical experience

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium chloride toxicity in the rat.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: evaluation of their in vitro effects on human neutrophil viability.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

AUR memorial Award. Induced alignment of flowing sickle erythrocytes in a magnetic field. A preliminary report

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Metal ion release from paramagnetic chelates: what is tolerable?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Cardiac electrophysiologic monitoring after injection of gadobenate dimeglumine versus placebo in healthy volunteers and patients with cardiovascular disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Gadodiamide administration causes spurious hypocalcemia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

Urine profiles and kidney histology after intravenous injection of ionic and nonionic radiologic and magnetic resonance contrast media in normal rats

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2709982

An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis

20 October 2018

1 reference

12 December 2020

Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy

1 reference

12 December 2020

Effects of lanthanum and gadolinium ions on cardiac sarcoplasmic reticulum

1 reference

12 December 2020

The gadolinium ion: A potent blocker of calcium channels and catecholamine release from cultured chromaffin cells

1 reference

12 December 2020

Characterization of Gd3+ and Tb3+ Binding Sites on Ca2+, Mg2+-Adenosine Triphosphatase of Sarcoplasmic Reticulum1

1 reference

12 December 2020

Gd-DOTA: characterization of a new paramagnetic complex

1 reference

12 December 2020

Safety assessment of gadopentetate dimeglumine in U.S. clinical trials

1 reference

12 December 2020

The relationship between thermodynamics and the toxicity of gadolinium complexes

1 reference

12 December 2020

Reaction of gadolinium chelates with endogenously available ions

1 reference

12 December 2020

Functional characterization of lanthanide binding sites in the sarcoplasmic reticulum calcium-ATPase: do lanthanide ions bind to the calcium transport site?

1 reference

12 December 2020

The Synthesis and Screening of Nonionic Gadolinium (III) DTPA-Bisamide Complexes as Magnetic Resonance Imaging Contrast Agents

1 reference

12 December 2020

Renal Tolerance of Gadolinium-DTPA/Dimeglumine in Patients with Chronic Renal Failure

1 reference

12 December 2020

Dissociation of gadolinium chelates in mice: relationship to chemical characteristics

1 reference

12 December 2020

Early effect of gadopentetate and iodinated contrast media on rabbit kidneys

1 reference

12 December 2020

Clinical safety of gadopentetate dimeglumine

1 reference

12 December 2020

Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats

1 reference

12 December 2020

Effects of gadolinium chloride on the rat lung following intratracheal instillation

1 reference

12 December 2020

Nephrotoxicity of high-dose gadolinium compared with iodinated contrast

1 reference

12 December 2020

Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media

1 reference

12 December 2020

Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents

1 reference

12 December 2020

Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans

1 reference

12 December 2020

Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation

1 reference

12 December 2020

Multihance clinical pharmacology: biodistribution and MR enhancement of the liver

1 reference

12 December 2020

Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme

1 reference

12 December 2020

Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

12 December 2020

Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment

1 reference

12 December 2020

Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy

1 reference

12 December 2020

1 reference

12 December 2020

Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis

1 reference

12 December 2020

Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure

1 reference

12 December 2020

Case-control study of gadodiamide-related nephrogenic systemic fibrosis

1 reference

12 December 2020

Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure

1 reference

12 December 2020

Quantification of gadodiamide as Gd in serum, peritoneal dialysate and faeces by inductively coupled plasma atomic emission spectroscopy and comparative analysis by high-performance liquid chromatography

1 reference

12 December 2020

Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency

1 reference

12 December 2020

Safety of gadolinium contrast agent in hemodialysis patients

1 reference

12 December 2020

Trends in adverse events after IV administration of contrast media

1 reference

12 December 2020

Identifiers

DOI

10.1002/JMRI.21135

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

PMCID

2709982